Endovia Health Sciences (EDVA) Operating Income Growth (1y) (2013 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | -36.55% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 99.51% |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -33.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.65% |
| Mar 31, 2026 | 40.97% |
| Dec 31, 2025 | -237.12% |
| Sep 30, 2025 | -257.53% |
| Jun 30, 2025 | 59.31% |
| Mar 31, 2025 | 48.98% |
| Dec 31, 2024 | 91.19% |
| Sep 30, 2024 | 38.25% |
| Jun 30, 2024 | 12.57% |
| Mar 31, 2024 | 5.92% |
| Dec 31, 2023 | 31.10% |
| Sep 30, 2023 | 15.41% |
| Jun 30, 2023 | 27.58% |
| Mar 31, 2023 | 39.22% |
| Dec 31, 2022 | 22.45% |
| Sep 30, 2022 | 57.66% |
| Jun 30, 2022 | 13.10% |
| Mar 31, 2022 | -24.95% |
| Dec 31, 2021 | 53.96% |
| Sep 30, 2021 | -458.03% |